Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
January 18, 2018
Rexahn Pharmaceuticals to Present at the American Society of Clinical Oncology Gastrointestinal Cancers (ASCO GI) 2018 Annual Meeting
ROCKVILLE, Md., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment ...
January 18, 2018
Arrowhead Pharmaceuticals Announces Pricing of Underwritten Public Offering of Common Stock
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock, offered at a ...
January 18, 2018
Paratek Announces Pricing of Public Offering of Common Stock
BOSTON, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
January 17, 2018
Gemphire Completes Patient Enrollment in INDIGO-1 Trial in Severe Hypertriglyceridemia (SHTG) Patients
LIVONIA, Mich., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, ...
January 17, 2018
Arcturus Therapeutics Announces Expansion of Collaboration with Takeda Pharmaceuticals to Develop RNA-based Therapeutics for the Treatment of Nonalcoholic Steatohepatitis (NASH) and Other GI Disorders
SAN DIEGO, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (ARCT), a leading RNA medicines company, announced today that it is extending its partnership ...
January 17, 2018
BioTime Announces Issuance of 41 New Patents to Expand and Bolster Its Patent Estate
ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE American: BTX), a late-stage, clinical biotechnology company developing and commercializing products addressing degenerative diseases, today announced the issuance of 41 ...
January 17, 2018
VBI Vaccines Announces Dosing of First GBM Patient in Phase 1/2a Clinical Study of VBI-1901
CAMBRIDGE, Mass., Jan. 17, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (VBIV) (VBV.TO) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, ...
January 17, 2018
MiMedx Announces the Enrollment of the First Patients in the Phase 3 Clinical Trial of AmnioFix® Injectable for Achilles Tendonitis
MARIETTA, Ga., Jan. 17, 2018 /PRNewswire/ -- MiMedx Group, Inc. (MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue ...
January 17, 2018
First Chronic Hepatitis B Patient Dosed in China in a Phase 1 Trial of T101 (Transgene’s TG1050 Technology)
STRASBOURG, France-- (BUSINESS WIRE) -- Regulatory News: Transgene (TNG.PA) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies, announces that the first patient has ...
December 20, 2017
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study of ARO-AAT
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced that it filed a regulatory submission to begin a first-in-human study of ARO-AAT, a second-generation investigational medicine ...
December 20, 2017
AzurRx BioPharma Announces Publication of U.S. Patent Application for AZX1101
BROOKLYN, N.Y., Dec. 20, 2017 (GLOBE NEWSWIRE) -- AzurRx BioPharma Inc.(AZRX) (“AzurRx” or the “Company”), today announced that the United States Patent and Trademark Office ...
December 20, 2017
HTG Molecular Diagnostics to Participate in Corporate Access Event in San Francisco, January 8 – 10, 2018
TUCSON, Ariz., Dec. 20, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM), a provider of instruments, reagents and services for molecular profiling applications, today ...
December 20, 2017
STRATA Skin Sciences Announces Appointment of LuAnn Via as Chairperson of the Board
HORSHAM, Pa., Dec. 20, 2017 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA”) (SSKN), today announced that effective immediately LuAnn Via, current Board member and ...
December 20, 2017
Eloxx Pharmaceuticals Completes Acquisition Transaction with Sevion Therapeutics
WALTHAM, Mass. and REHOVOT, Israel and SAN DIEGO, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals Ltd. (“Eloxx”) and Sevion Therapeutics, Inc. (SVON) (“Sevion”) today announced the two ...
December 20, 2017
Opiant Pharmaceuticals Announces Significant Financial Developments Related to NARCAN® Nasal Spray for Opioid Overdose
SANTA MONICA, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced ...
December 20, 2017
PolarityTE™ Announces a New 200,000 sq ft Polarity Campus and Corporate Headquarters to Meet the Demand for SkinTE™ and Accelerate Core Technology Platforms into 2018
SALT LAKE CITY, Dec. 20, 2017 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (COOL) today officially announced that the company has continued to expand its R&D and ...
December 20, 2017
BioDelivery Sciences Appoints Scott Plesha to President
RALEIGH, N.C., Dec. 20, 2017 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (BDSI) announced the appointment of Scott Plesha, currently Senior Vice President of Sales ...
December 20, 2017
Catalyst Biosciences Announces Pricing of Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
December 18, 2017
Sensorion and Cochlear Announce Collaboration to Study Combination Therapies for Cochlear Implant Patients
MONTPELLIER, France and SYDNEY, Australia, Dec. 18, 2017 (GLOBE NEWSWIRE) --  Sensorion (FR0012596468 – ALSEN) a biotech company pioneering novel treatments for inner ear diseases, ...
December 18, 2017
BioDelivery Sciences Announces Notice of Allowance of Patent Strengthening Patent Protection on BELBUCA® to 2032
RALEIGH, N.C., Dec. 18, 2017 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (BDSI) announced that the U.S. Patent and Trademark Office has issued a Notice ...
Page 71 of 117